Skip to main content

Advertisement

Table 2 CNV Regions identified in discovery phase (MBCFS) and evaluated in replication cohort (Mayo VTE)

From: The association of copy number variation and percent mammographic density

Chromosome Start position End position Number significant probesa
MBCFS (discovery) Mayo VTE (replication)
3 163,995,377 164,008,284 17 1
3 164,030,569 164,108,060 13 0
8 133,134,063 133,144,009 6 0
11 11,779,614 11,780,713 17 0
17 47,649,105 47,667,700 3 3
  1. MBCFS Mayo Breast Cancer Family Study and Mayo VTE Mayo Venous Thromboembolism Case–Control Study.
  2. aSignificant associations defined as p < 0.0001 for discovery phase and p < 0.05 for replication.